Park Soo-Kyung, Hwang Sung Wook, Kim Kyeong Ok, Cha Jae Myung, Boo Sun-Jin, Shin Jeong Eun, Joo Young-Eun, Jung Yunho, Lee Jun, Yang Hyo-Joon, Park Dong Il
Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Gastroenterology, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea.
J Gastroenterol Hepatol. 2017 Apr;32(4):803-808. doi: 10.1111/jgh.13626.
The number of patients with >10 adenomas is relatively small, and few studies have investigated the risk of colorectal neoplasm (CRN) in these patients. Thus, we aimed to investigate the risk of developing CRN in patients with >10 adenomas and to compare their risk with that of patients with 3-10 adenomas.
A retrospective multicenter cohort study that included 214 patients with >10 adenomas on index colonoscopy performed between January 2009 and December 2011, and underwent follow-up colonoscopy until December 2015 was conducted. The risk of developing advanced CRN (cancer or advanced adenoma with a diameter of ≥10 mm or with a villous component, or high-grade dysplasia) was investigated and compared with that in patients with 3-10 adenomas (n = 975).
Among the 214 patients with >10 adenomas, the mean age was 62.9 years and the mean number of adenomas on index colonoscopy was 14.2. Overall, 57 patients (26.6%) developed an advanced CRN after a mean of 4.3 years from baseline colonoscopy. The respective 3- and 5-year cumulative risks of advanced CRN were 6.8% (95% confidence interval [CI] 2.9-10.7) and 28.7% (95% CI 20.8-36.5), higher than those in the group with 3-10 adenomas (n = 975, P = 0.001). Having >10 adenomas on index colonoscopy was an independent risk factor for developing advanced CRN (odds ratio 2.25, 95% CI 1.49-3.38).
The risk of developing advanced CRN in patients with >10 adenomas was high and statistically higher than that in patients with 3-10 adenomas. Further prospective studies are needed to investigate whether a more intensive surveillance is needed in this group.
腺瘤数量超过10个的患者数量相对较少,很少有研究调查这些患者发生结直肠肿瘤(CRN)的风险。因此,我们旨在调查腺瘤数量超过10个的患者发生CRN的风险,并将其风险与腺瘤数量为3至10个的患者进行比较。
进行了一项回顾性多中心队列研究,纳入了2009年1月至2011年12月期间初次结肠镜检查发现腺瘤数量超过10个的214例患者,并对其进行随访结肠镜检查直至2015年12月。研究了发生进展期CRN(癌症或直径≥10 mm或具有绒毛成分或高级别上皮内瘤变的进展性腺瘤)的风险,并与腺瘤数量为3至10个的患者(n = 975)进行比较。
在214例腺瘤数量超过10个的患者中,平均年龄为62.9岁,初次结肠镜检查时腺瘤的平均数量为14.2个。总体而言,57例患者(26.6%)在距基线结肠镜检查平均4.3年后发生了进展期CRN。进展期CRN的3年和5年累积风险分别为6.8%(95%置信区间[CI] 2.9 - 10.7)和28.7%(95% CI 20.8 - 36.5),高于腺瘤数量为3至10个的组(n = 975,P = 0.001)。初次结肠镜检查时腺瘤数量超过10个是发生进展期CRN的独立危险因素(比值比2.25,95% CI 1.49 - 3.38)。
腺瘤数量超过10个的患者发生进展期CRN的风险较高,且在统计学上高于腺瘤数量为3至10个的患者。需要进一步的前瞻性研究来调查该组患者是否需要更密集的监测。